2014 Q3 Form 10-Q Financial Statement

#000107997314000421 Filed on August 11, 2014

View on sec.gov

Income Statement

Concept 2014 Q3 2014 Q2 2013 Q2
Revenue $36.00K
YoY Change -35.71%
Cost Of Revenue $12.39K
YoY Change -41.63%
Gross Profit $24.00K
YoY Change -31.43%
Gross Profit Margin 66.67%
Selling, General & Admin $1.473M $1.675M $1.354M
YoY Change 11.36% 23.66% -2.83%
% of Gross Profit 6138.75%
Research & Development $1.119M $950.1K $1.801M
YoY Change -38.04% -47.23% 104.46%
% of Gross Profit 4663.81%
Depreciation & Amortization $47.00K $51.00K $64.00K
YoY Change -68.67% -20.31% -31.18%
% of Gross Profit 195.83%
Operating Expenses $2.593M $2.625M $3.155M
YoY Change -17.15% -16.8% 38.72%
Operating Profit -$2.545M -$2.601M -$3.134M
YoY Change -17.19% -17.01% 39.45%
Interest Expense $27.19K $25.77K $30.75K
YoY Change -14.76% -16.19%
% of Operating Profit
Other Income/Expense, Net $11.16K $9.173K -$11.02K
YoY Change 1464.52% -183.27% -82.42%
Pretax Income -$2.530M -$2.590M -$3.140M
YoY Change -17.59% -17.52% 35.93%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.533M -$2.592M -$3.145M
YoY Change -17.55% -17.6% 36.15%
Net Earnings / Revenue -7036.11%
Basic Earnings Per Share
Diluted Earnings Per Share -$653.7K -$672.7K -$1.707M
COMMON SHARES
Basic Shares Outstanding 30.99M shares 30.97M shares 9.954M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q3 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.70M $29.10M $20.00M
YoY Change 54.34% 45.5% 78.57%
Cash & Equivalents $4.371M $3.753M $9.737M
Short-Term Investments $22.30M $25.30M $10.30M
Other Short-Term Assets $500.0K $300.0K $100.0K
YoY Change 0.0% 200.0% 0.0%
Inventory
Prepaid Expenses
Receivables $12.00K $36.00K
Other Receivables
Total Short-Term Assets $27.25M $29.37M $20.11M
YoY Change 52.7% 46.01% 77.51%
LONG-TERM ASSETS
Property, Plant & Equipment $2.132M $2.167M $2.377M
YoY Change -8.08% -8.84% -8.9%
Goodwill $387.2K $387.2K $387.2K
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.667M $1.674M $1.610M
YoY Change 3.18% 4.01% 1.78%
Total Long-Term Assets $3.799M $3.841M $3.987M
YoY Change -3.45% -3.65% -4.87%
TOTAL ASSETS
Total Short-Term Assets $27.25M $29.37M $20.11M
Total Long-Term Assets $3.799M $3.841M $3.987M
Total Assets $31.05M $33.21M $24.10M
YoY Change 42.55% 37.8% 55.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $521.4K $499.9K $874.9K
YoY Change -40.09% -42.86% 100.76%
Accrued Expenses $463.4K $543.9K $884.1K
YoY Change -52.34% -38.48% 141.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $400.0K $200.0K $100.0K
YoY Change 0.0% 100.0% -88.89%
Total Short-Term Liabilities $1.788M $1.567M $2.034M
YoY Change -25.51% -23.0% 2.86%
LONG-TERM LIABILITIES
Long-Term Debt $2.000M $2.100M $2.200M
YoY Change -9.09% -4.55% -8.33%
Other Long-Term Liabilities $1.300M $1.300M $1.200M
YoY Change 0.0% 8.33% 500.0%
Total Long-Term Liabilities $3.300M $3.400M $3.400M
YoY Change -5.71% 0.0% 30.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.788M $1.567M $2.034M
Total Long-Term Liabilities $3.300M $3.400M $3.400M
Total Liabilities $5.108M $4.948M $5.492M
YoY Change -13.62% -9.9% 20.58%
SHAREHOLDERS EQUITY
Retained Earnings -$94.45M -$91.92M -$80.18M
YoY Change 13.46% 14.64% 15.75%
Common Stock $98.79M
YoY Change 23.12%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $25.94M $28.26M $18.61M
YoY Change
Total Liabilities & Shareholders Equity $31.05M $33.21M $24.10M
YoY Change 42.55% 37.8% 55.27%

Cashflow Statement

Concept 2014 Q3 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income -$2.533M -$2.592M -$3.145M
YoY Change -17.55% -17.6% 36.15%
Depreciation, Depletion And Amortization $47.00K $51.00K $64.00K
YoY Change -68.67% -20.31% -31.18%
Cash From Operating Activities -$2.290M -$2.120M -$1.890M
YoY Change -10.89% 12.17% 42.11%
INVESTING ACTIVITIES
Capital Expenditures -$20.00K -$70.00K -$30.00K
YoY Change -33.33% 133.33% 0.0%
Acquisitions
YoY Change
Other Investing Activities $3.040M -$16.48M -$3.480M
YoY Change -213.43% 373.56% -1094.29%
Cash From Investing Activities $3.010M -$16.54M -$3.520M
YoY Change -211.48% 369.89% -1200.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -100.0K 18.44M 12.64M
YoY Change 0.0% 45.89% 18.69%
NET CHANGE
Cash From Operating Activities -2.290M -2.120M -1.890M
Cash From Investing Activities 3.010M -16.54M -3.520M
Cash From Financing Activities -100.0K 18.44M 12.64M
Net Change In Cash 620.0K -220.0K 7.230M
YoY Change -111.55% -103.04% -25.0%
FREE CASH FLOW
Cash From Operating Activities -$2.290M -$2.120M -$1.890M
Capital Expenditures -$20.00K -$70.00K -$30.00K
Free Cash Flow -$2.270M -$2.050M -$1.860M
YoY Change -10.63% 10.22% 43.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
245933 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
1912205 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
3673126 shares
CY2014Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
326235 USD
CY2013Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
410529 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
729074 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
894154 USD
CY2014Q2 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
157 USD
CY2013Q2 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
597 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
339 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1193 USD
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
326392 USD
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
411126 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
895347 USD
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
543873 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
907732 USD
CY2014Q2 us-gaap Notes Payable Current
NotesPayableCurrent
150118 USD
CY2014Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
96698 USD
CY2014Q2 us-gaap Assets
Assets
33210644 USD
CY2013Q4 us-gaap Assets
Assets
18639869 USD
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
499949 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
780514 USD
CY2014Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
275922 USD
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
148922 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
92084 USD
us-gaap Operating Expenses
OperatingExpenses
5994780 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2600692 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3133603 USD
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
USD
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
30990029 shares
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3752767 USD
CY2014Q2 us-gaap Short Term Investments
ShortTermInvestments
25348142 USD
CY2013Q4 us-gaap Short Term Investments
ShortTermInvestments
8642648 USD
CY2014Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
268681 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
459396 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
29369590 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
14760727 USD
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2166600 USD
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1674454 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1566560 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2249023 USD
CY2014Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
2074328 USD
CY2014Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1307062 USD
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1290441 USD
CY2014Q2 us-gaap Liabilities
Liabilities
4947950 USD
CY2013Q4 us-gaap Liabilities
Liabilities
5690072 USD
CY2013Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30990029 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21454380 shares
CY2014Q2 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
120183650 USD
CY2013Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
99331585 USD
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-91920956 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-86381788 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
28262694 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
12949797 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33210644 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18639869 USD
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30990029 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21454380 shares
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2014Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
USD
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
USD
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
USD
us-gaap Gross Profit
GrossProfit
USD
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
USD
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
51728 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
31907 USD
us-gaap Gross Profit
GrossProfit
19821 USD
CY2014Q2 us-gaap Licenses Revenue
LicensesRevenue
24174 USD
CY2013Q2 us-gaap Licenses Revenue
LicensesRevenue
21249 USD
us-gaap Licenses Revenue
LicensesRevenue
47349 USD
us-gaap Licenses Revenue
LicensesRevenue
39904 USD
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1674719 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1354330 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3569161 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2782285 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
950147 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1800522 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2002445 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3212495 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
2624866 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
3154852 USD
us-gaap Operating Expenses
OperatingExpenses
5571606 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1241227 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5658683 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5504436 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5954876 USD
CY2014Q2 us-gaap Interest Expense
InterestExpense
25768 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
30747 USD
us-gaap Interest Expense
InterestExpense
62558 USD
us-gaap Interest Expense
InterestExpense
74806 USD
CY2014Q2 us-gaap Investment Income Net
InvestmentIncomeNet
34941 USD
CY2013Q2 us-gaap Investment Income Net
InvestmentIncomeNet
19731 USD
us-gaap Investment Income Net
InvestmentIncomeNet
27826 USD
us-gaap Investment Income Net
InvestmentIncomeNet
32241 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
50653 USD
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9173 USD
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11016 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-34732 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8088 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-2591519 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-3144619 USD
us-gaap Net Income Loss
NetIncomeLoss
-5539168 USD
us-gaap Net Income Loss
NetIncomeLoss
-5946788 USD
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.48
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30782937 shares
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14756578 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26236252 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12368745 shares
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
729413 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
153592 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
171797 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
2951 USD
us-gaap Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
47349 USD
us-gaap Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
39904 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18943 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-209658 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-266316 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-280565 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
260992 USD
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
127000 USD
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-406414 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-363859 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
242053 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
68584 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
196860 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4961637 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4356790 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
28420458 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
12504775 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
11714964 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
3411351 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2200 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22911 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
113304 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
51992 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-16820998 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-9168327 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
685697 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
20122652 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12969587 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
19876719 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
12283890 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1905916 USD
us-gaap Depreciation
Depreciation
131000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1612160 USD
CY2014Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
21000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
41000 USD
CY2013Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10977974 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9736747 USD
us-gaap Interest Paid
InterestPaid
52928 USD
us-gaap Interest Paid
InterestPaid
81647 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
USD
CY2014Q2 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
USD
CY2014Q2 us-gaap Investments And Cash
InvestmentsAndCash
29101000 USD
CY2014Q2 appy Working Capital
WorkingCapital
27803000 USD
CY2014Q2 appy Percentage Of Investment Portfolio Cash And Cash Equivalent
PercentageOfInvestmentPortfolioCashAndCashEquivalent
0.09 pure
us-gaap Trading Securities Unrealized Holding Loss
TradingSecuritiesUnrealizedHoldingLoss
46000 USD
us-gaap Trading Securities Realized Loss
TradingSecuritiesRealizedLoss
117000 USD
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
12000 USD
us-gaap Trading Securities Unrealized Holding Loss
TradingSecuritiesUnrealizedHoldingLoss
51000 USD
us-gaap Trading Securities Realized Loss
TradingSecuritiesRealizedLoss
28000 USD
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
7000 USD
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
36000 USD
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5251000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5844000 shares
CY2014Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5499299 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5497099 USD
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3332699 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3230117 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2266982 USD
CY2014Q2 us-gaap Depreciation
Depreciation
51000 USD
us-gaap Depreciation
Depreciation
103000 USD
CY2013Q2 us-gaap Depreciation
Depreciation
64000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
41000 USD
CY2013Q2 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
3000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
463147 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
422261 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1287215 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1214797 USD
CY2014Q2 us-gaap Goodwill
Goodwill
387239 USD
CY2013Q4 us-gaap Goodwill
Goodwill
387239 USD
CY2013Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
10124 USD
CY2014Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
81000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
81000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
81000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
81000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
81000 USD
CY2014Q2 us-gaap Secured Debt
SecuredDebt
2224446 USD
CY2013Q4 us-gaap Secured Debt
SecuredDebt
2296919 USD
CY2013Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
173460 USD
CY2014Q2 us-gaap Notes Payable
NotesPayable
2224446 USD
CY2013Q4 us-gaap Notes Payable
NotesPayable
2470379 USD
CY2013Q4 us-gaap Notes Payable Current
NotesPayableCurrent
319771 USD
CY2013Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
2150608 USD
CY2014Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
74000 USD
CY2014Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
153000 USD
CY2014Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
159000 USD
CY2014Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
166000 USD
CY2014Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
1268000 USD
CY2014Q2 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
404000 USD
CY2014Q2 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
USD
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
8335000 shares
CY2014Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
2.40
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
20000000 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1543000 USD
appy Placement Fee Percentage
PlacementFeePercentage
0.065 pure
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
39079 shares
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
82000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
14000 USD
CY2013 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
11500000 shares
CY2013Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.25
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
14400000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1405000 USD
CY2013 appy Placement Fee Percentage
PlacementFeePercentage
0.07 pure
CY2013Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
0.35 shares
CY2013Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
4025000 shares
CY2013Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.36
CY2013 appy Underwriter Addtional Shares Percentage
UnderwriterAddtionalSharesPercentage
0.15 pure
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
1161570 shares
CY2014Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.36
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1580000 USD
CY2014Q2 appy License And Milestone Payments Revenue
LicenseAndMilestonePaymentsRevenue
1920000 USD
CY2014Q2 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
363700 USD
CY2014Q2 appy Deferred Revenue Gross
DeferredRevenueGross
1556300 USD
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P197M
CY2014Q2 us-gaap Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
20000 USD
CY2014Q2 appy License Agreement Maximum Milestone Payments
LicenseAgreementMaximumMilestonePayments
1100000 USD
CY2014Q2 appy Additional Milestone Maximum Payments
AdditionalMilestoneMaximumPayments
2000000 USD
CY2014Q2 appy Deferred Revenue Accumulated Recognition
DeferredRevenueAccumulatedRecognition
152540 USD
CY2014Q2 us-gaap Deferred Revenue
DeferredRevenue
1403760 USD
dei Entity Registrant Name
EntityRegistrantName
Venaxis, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001167419
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Amendment Flag
AmendmentFlag
false

Files In Submission

Name View Source Status
0001079973-14-000421-index-headers.html Edgar Link pending
0001079973-14-000421-index.html Edgar Link pending
0001079973-14-000421.txt Edgar Link pending
0001079973-14-000421-xbrl.zip Edgar Link pending
appy-20140630.xml Edgar Link completed
appy-20140630.xsd Edgar Link pending
appy-20140630_cal.xml Edgar Link unprocessable
appy-20140630_def.xml Edgar Link unprocessable
appy-20140630_lab.xml Edgar Link unprocessable
appy-20140630_pre.xml Edgar Link unprocessable
appy_10q-063014.htm Edgar Link pending
ex31x1.htm Edgar Link pending
ex31x2.htm Edgar Link pending
ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending